SCHEMBL14933402

SCHEMBL14933402

O=c1c2c3ccccc3ncc2c2ccccc2n1-c1cc(-c2ccccc2)cc(-c2ccccc2)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.40
MEN1 O00255 3/20 0.40
HSD17B10 Q99714 2/20 0.40
ALDH1A1 P00352 1/20 0.40
POLB P06746 1/20 0.40
TSHR P16473 1/20 0.40
BRCA1 P38398 1/20 0.40
HSP90AA1 P07900 1/20 0.37
MAPT P10636 1/20 0.37
GABRA1 P14867 3/20 0.36
GABRG2 P18507 3/20 0.36
GABRB3 P28472 3/20 0.36
GABRA5 P31644 3/20 0.36
GABRA3 P34903 3/20 0.36
GABRA2 P47869 3/20 0.36
GABRA6 Q16445 3/20 0.36
HDAC6 Q9UBN7 1/20 0.36
CASP1 P29466 1/20 0.36
MAPK10 P53779 1/20 0.36
CASP7 P55210 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14933412 0.87 KDM4E (0.49) KMT2AMEN1HSD17B10ALDH1A1POLB
SCHEMBL19037011 0.82 TLR7 (0.41) KMT2AMEN1HSP90AA1MAPTTLR7
SCHEMBL14933341 0.78 KMT2A (0.53) KMT2AMEN1HSD17B10ALDH1A1POLB
SCHEMBL14933438 0.77 KMT2A (0.41) KMT2AMEN1HSD17B10ALDH1A1POLB
SCHEMBL14933480 0.77 MAPK1 (0.41) KMT2AMEN1POLBHSP90AA1MAPT
SCHEMBL14933410 0.76 KMT2A (0.47) KMT2AMEN1HSD17B10ALDH1A1POLB
SCHEMBL14933505 0.74 MAPT (0.44) KMT2AMEN1HSD17B10ALDH1A1POLB
SCHEMBL15513582 0.74 L3MBTL1 (0.61) KMT2AMEN1HSD17B10ALDH1A1POLB
SCHEMBL10128493 0.74 L3MBTL1 (0.61) KMT2AMEN1HSD17B10ALDH1A1POLB
SCHEMBL10090522 0.74 L3MBTL1 (0.61) KMT2AMEN1HSD17B10ALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200216391-A1 COMPOSITION FOR ORGANIC ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2020-07-09 US disclosed
WO-2019007867-A1 COMPOSITION FOR ORGANIC ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2019-01-10 WO disclosed
US-9337430-B2 Organic electroluminescent device MERCK PATENT GMBH (DE) 2016-05-10 US disclosed
US-9337430-B2 Organic electroluminescent device MERCK PATENT GMBH (DE) 2016-05-10 US disclosed
EP-2773721-B1 ORGANIC ELECTROLUMINESCENT DEVICE MERCK PATENT GMBH (DE) 2015-11-25 EP disclosed
US-20140249308-A1 ORGANIC ELECTROLUMINESCENT DEVICE MERCK PATENT GMBH (DE) 2014-09-04 US disclosed
US-20140249308-A1 ORGANIC ELECTROLUMINESCENT DEVICE MERCK PATENT GMBH (DE) 2014-09-04 US disclosed
WO-2013064206-A1 ORGANIC ELECTROLUMINESCENT DEVICE MERCK PATENT GMBH (DE) 2013-05-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200216391-A1 COMPOSITION FOR ORGANIC ELECTRONIC DEVICES SLCO2B1, SLCO4C1, SLCO2A1 KMT2A 3888/4885MEN1 2556/4885HSD17B10 790/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.